EPIZYME, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/acfb7d28-4e16-42d1-9b94-8fed6e84da38/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $37.4M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-002552 |
| FY 2020 | $15.8M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-007292 |
| FY 2019 | $23.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-21-007292 |
| FY 2018 | $21.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-21-007292 |
| FY 2017 | $10.0M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004237 |
| FY 2016 | $8.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004237 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).